Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • Mikey
    Junior Member
    • Dec 2018
    • 1

    #1

    Converting indels through to AminoAcid change

    Hello
    I am paused at a part in my project of analysing a genome for a rare neurological presentation (extremely rare- prevalence of only a few in the literature). The rare part being the symptom which is visual in nature, the neuroradiological etiology being very common in neurological disorders- white matter degradation.
    Ive found a gene of particular interest. The mutations in this gene are all indels. No SNP, no CNV.
    To work out whether its likely pathological i need to work out if the change leads to a loss or gain of a cysteine residue within one of the EGFRs of NOTCH3 extracellular domain.
    Ive found 7 mutations within the 23 exons which code for the epidermal growth factor-like repeat domains im wondering if someone could please give me an indication as to how i advance further on this to work out if they lead to a loss or gain of cysteine residue
    Thanks
    Mikey

Latest Articles

Collapse

  • SEQadmin2
    Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
    by SEQadmin2



    Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

    Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
    ...
    10-14-2026, 09:55 AM
  • SEQadmin2
    New Genomics Technologies Take Aim at Long-Standing Limits
    by SEQadmin2


    Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.

    We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing
    ...
    09-28-2026, 10:25 AM

ad_right_rmr

Collapse

News

Collapse

Topics Statistics Last Post
Started by SEQadmin2, 10-22-2026, 11:13 AM
0 responses
39 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-22-2026, 10:48 AM
0 responses
28 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-15-2026, 10:52 AM
0 responses
41 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-14-2026, 05:39 AM
0 responses
45 views
0 reactions
Last Post SEQadmin2  
Working...